News

March 2025: MyoPAXon featured in MDA Quest Magazine

July 2024: FDA Clears Investigational New Drug application for muscular dystrophy treatment from University of Minnesota startup Myogenica

April 2024: Duchenne UK and PPMD Award $500,000 to Evaluate Safety, Tolerability of Muscle Progenitor Cells in Phase 1 Trial